BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.480
-0.150 (-9.20%)
At close: Feb 21, 2025, 4:00 PM
1.500
+0.020 (1.35%)
After-hours: Feb 21, 2025, 7:59 PM EST
BioVie Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Selling, General & Admin | 9.26 | 8.85 | 11.55 | 9.77 | 4.64 | 1.31 | |
Research & Development | 14.45 | 23.1 | 33.3 | 17.26 | 133.19 | 1.15 | |
Operating Expenses | 23.94 | 32.18 | 45.08 | 27.25 | 138.05 | 2.69 | |
Operating Income | -23.94 | -32.18 | -45.08 | -27.25 | -138.05 | -2.69 | |
Interest Expense | -1.39 | -2.89 | -4.3 | -2.16 | -0.56 | -4.77 | |
Interest & Investment Income | 0.93 | 1.14 | 0.56 | 0.04 | 0.02 | 0 | |
Other Non Operating Income (Expenses) | 0.12 | 1.82 | -1.44 | 3.29 | 8.28 | -9.21 | |
EBT Excluding Unusual Items | -24.27 | -32.12 | -50.26 | -26.08 | -130.31 | -16.68 | |
Other Unusual Items | - | - | - | - | 0.06 | - | |
Pretax Income | -24.27 | -32.12 | -50.26 | -26.08 | -130.25 | -16.68 | |
Net Income | -24.27 | -32.12 | -50.26 | -26.08 | -130.25 | -16.68 | |
Preferred Dividends & Other Adjustments | 1.26 | 0.89 | - | - | 53.6 | 17.1 | |
Net Income to Common | -25.53 | -33.01 | -50.26 | -26.08 | -183.85 | -33.78 | |
Shares Outstanding (Basic) | 8 | 5 | 3 | 2 | 1 | 0 | |
Shares Outstanding (Diluted) | 8 | 5 | 3 | 2 | 1 | 0 | |
Shares Change (YoY) | 123.13% | 39.10% | 31.71% | 98.84% | 151.61% | 94.10% | |
EPS (Basic) | -3.13 | -7.30 | -15.47 | -10.58 | -148.23 | -68.52 | |
EPS (Diluted) | -3.13 | -7.30 | -15.47 | -10.60 | -148.23 | -68.52 | |
Free Cash Flow | -22.02 | -27.95 | -40.25 | -18.99 | -10.45 | -1.63 | |
Free Cash Flow Per Share | -2.70 | -6.18 | -12.39 | -7.70 | -8.43 | -3.30 | |
EBITDA | -23.71 | -31.95 | -44.85 | -27.02 | -137.82 | -2.46 | |
D&A For EBITDA | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | |
EBIT | -23.94 | -32.18 | -45.08 | -27.25 | -138.05 | -2.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.